Pain Management,Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine

Last Modified: 11/18/2021 10:10:48 AM


Medical Necessity Documentation:  
Client Notes:  Please contact 266-1500 (Option 1) to acquire the appropriate specimen type
Patient Preparation:  
Specimen Requirements:

20.0 mL Urine in a Green Clinical Drug Test Collection Cup

Collection Instructions:  
Minimum Volume: 5.0 mL Urine
Transport & Storage: Temperature/Stability:

5 days Ambient
7 days Refrigerated
30 days Frozen

Transport Ambient

Rejection Criteria: preserved samples
Reference Range: Ritalinic Acid  <100 ng/mL
Critical Ranges:  
Test Comments:  
Methodology: Mass Spectrometry (MS)
Clinical Significance: Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine - The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications arent diverted, and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s)
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 3 to 4 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: MPDEM
EPIC Test Code: LAB2852
Send Out Test Code: 39409
Alternate Test Names: Methylphenidate Metabolite, Quantitative, with me; Drug Monitoring, Methylphenidate Metabolite, Quant
Included Tests:

Ritalinic Acid

CPT Coding: 80360 (MCR: G0480)

Go back to the top of the page.